The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has completed its acquisition of Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization, for approximately...
PCI Pharma Services (PCI) has agreed to acquire Sherpa Clinical Packaging (Sherpa), a San Diego, California-based provider of clinical-trial supply services. The addition of Sherpa’s capabilities enables PCI to support customers from early phases...
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has acquired Sandoz’s sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of...
Thermo Fisher Scientific has agreed to acquire the advanced bioprocessing business of Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company.
The bioprocessing business combines a technical services...
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego.
The...
Olon S.p.A., an Italy-headquartered contract development and manufacturing organization of active pharmaceutical ingredients (APIs) and a generics supplier, has acquired a local generics chemical operations API manufacturing facility in Mahad,...
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, is increasing manufacturing capacity at its Copenhagen, Denmark facility.
The Copenhagen facility will add a single-use bioreactor...
Kaneka Corporation, a Tokyo-headquartered chemical manufacturing company, has installed continuous manufacturing equipment for small-molecule pharmaceutical products at Kaneka’s Singapore facility. Kaneka announced the installment in July 2018 and...
Gerresheimer, a manufacturer of special glass and plastic products to the pharmaceutical industry, has agreed to acquire Sensile Medical AG, an Olten, Switzerland-based medical technology company, in a deal worth up to EUR 350 million ($409...
Sterigenics, a provider of contract sterilization, gamma technologies and medical isotopes, is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK.
The new 60,000-square-foot facility will include the installation of a...
West Pharmaceutical Services, a manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has opened a new facility in Waterford, Ireland, a global center of excellence for West's manufacturing network, and has...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has agreed to acquire Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing...
PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, has appointed Salim Haffar, as Chief Executive Officer to take effect later in 2018. Haffar is currently President of Aptar Pharma, a manufacturer of...
AGC, a Tokyo-headquartered manufacturer of glass and chemicals, is planning an expansion of its facilities in Chiba, Japan to increase the company’s manufacturing capacity for pharmaceutical intermediates and active pharmaceutical ingredients...
SK Holdings, a Seoul, South Korea-based holding company of SK Group, has agreed to acquire Ampac Fine Chemicals (AFC), a Rancho Cordova, California-headquartered contract manufacturer of active pharmaceutical ingredients (APIs) and intermediates....
